Karin Eastham

Track

Insider profile

Currently holds positions in Geron Corp, Veracyte Inc, Nektar Therapeutics and Personalis Inc

Positions

Position Company Period
Independent Director Geron Corp March 30, 2009 -
Independent Director Veracyte Inc Dec. 1, 2012 -
Independent Director Nektar Therapeutics Sept. 26, 2018 -
Independent Director Personalis Inc Sept. 9, 2019 -
Independent Director Illumina Inc July 1, 2004 - May 29, 2019
Independent Member of the Supervisory Board MorphoSys AG Jan. 1, 2015 - May 17, 2017
Member of the Supervisory Board MorphoSys AG May 31, 2012 - Jan. 1, 2015
Independent Director Amylin Pharmaceuticals LLC Sept. 22, 2005 - Aug. 8, 2012
Karin Eastham's trades of Veracyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18
US Veracyte Inc (VCYT)
PlS Planned sale
71,654 -38.4%
252.98
US$4,656,263 		71,654 -38.4% 252.98 US$4,656,263
2026-06-22 2026-06-18
US Veracyte Inc (VCYT)
PlS Planned sale
15,617 +45.1%
222.06
US$4,043,639 		15,617 +45.1% 222.06 US$4,043,639
2026-06-18 2026-06-18
US Veracyte Inc (VCYT)
PrS Proposed sale
71,025
59.78
US$4,319,368 		71,025 59.78 US$4,319,368
2025-12-08 2025-12-05
US Veracyte Inc (VCYT)
PlS Planned sale
800 -5.6%
46.59
US$37,272 		800 -5.6% 46.59 US$37,272
2025-12-08 2025-12-05
US Veracyte Inc (VCYT)
PlS Planned sale
12,808 -47.2%
45.84
US$587,080 		12,808 -47.2% 45.84 US$587,080
2025-12-08 2025-12-05
US Veracyte Inc (VCYT)
PlS Planned sale
6,392 -19.0%
44.52
US$284,571 		6,392 -19.0% 44.52 US$284,571
2025-12-05 2025-12-05
US Veracyte Inc (VCYT)
PrS Proposed sale
20,000
47.41
US$948,200 		20,000 47.41 US$948,200
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
9,674 -41.6%
40.02
US$387,191 		9,674 -41.6% 40.02 US$387,191
2025-11-05 2025-11-05
US Veracyte Inc (VCYT)
PrS Proposed sale
9,674
36.12
US$349,425 		9,674 36.12 US$349,425
2025-06-17 2025-06-13
US Veracyte Inc (VCYT)
PlS Planned sale
4,590 -24.8%
26.66
US$122,388 		4,590 -24.8% 26.66 US$122,388
2025-06-13 2025-06-13
US Veracyte Inc (VCYT)
PrS Proposed sale
4,590
26.69
US$122,507 		4,590 26.69 US$122,507
2025-01-06 2025-01-02
US Veracyte Inc (VCYT)
PlS Planned sale
4,691 -20.2%
40.50
US$189,996 		4,691 -20.2% 40.50 US$189,996
2025-01-06 2025-01-02
US Veracyte Inc (VCYT)
PlS Planned sale
5,309 -18.6%
40.12
US$213,010 		5,309 -18.6% 40.12 US$213,010
2025-01-02 2025-01-02
US Veracyte Inc (VCYT)
PrS Proposed sale
10,000
39.60
US$396,000 		10,000 39.60 US$396,000
2024-11-21 2024-11-19
US Veracyte Inc (VCYT)
PlS Planned sale
10,125 -35.4%
38.76
US$392,404 		10,125 -35.4% 38.76 US$392,404
2024-11-21 2024-11-19
US Veracyte Inc (VCYT)
PlS Planned sale
3,006 -9.5%
37.77
US$113,538 		3,006 -9.5% 37.77 US$113,538
2024-11-21 2024-11-19
US Veracyte Inc (VCYT)
PlS Planned sale
1,600 -4.8%
36.77
US$58,826 		1,600 -4.8% 36.77 US$58,826
2024-11-19 2024-11-19
US Veracyte Inc (VCYT)
PrS Proposed sale
14,731
36.71
US$540,775 		14,731 36.71 US$540,775
2024-07-18 2024-07-16
US Veracyte Inc (VCYT)
PlS Planned sale
7,500 -18.4%
25.00
US$187,500 		7,500 -18.4% 25.00 US$187,500
2024-07-16 2024-07-16
US Veracyte Inc (VCYT)
PrS Proposed sale
7,500
25.00
US$187,500 		7,500 25.00 US$187,500
2024-06-13 2024-06-11
US Veracyte Inc (VCYT)
PlS Planned sale
3,870 -11.7%
20.59
US$79,683 		3,870 -11.7% 20.59 US$79,683
2024-06-11 2024-06-11
US Veracyte Inc (VCYT)
PrS Proposed sale
3,870
20.59
US$79,683 		3,870 20.59 US$79,683
2024-06-11 2024-06-07
US Veracyte Inc (VCYT)
PlS Planned sale
2,500 -7.0%
20.97
US$52,425 		2,500 -7.0% 20.97 US$52,425
2024-06-07 2024-06-07
US Veracyte Inc (VCYT)
PrS Proposed sale
2,500
20.97
US$52,425 		2,500 20.97 US$52,425
2024-04-02 2024-04-01
US Veracyte Inc (VCYT)
PlS Planned sale
10,000 -23.2%
21.65
US$216,528 		10,000 -23.2% 21.65 US$216,528
2024-04-01 2024-04-01
US Veracyte Inc (VCYT)
PrS Proposed sale
10,000
21.65
US$216,528 		10,000 21.65 US$216,528
2023-03-17 2023-03-16
US Veracyte Inc (VCYT)
PlS Planned sale
18,750 -44.4%
22.78
US$427,044 		18,750 -44.4% 22.78 US$427,044
2023-03-02 2023-02-28
US Veracyte Inc (VCYT)
PlS Planned sale
10,000 -29.9%
25.00
US$250,001 		10,000 -29.9% 25.00 US$250,001
2022-09-14 2022-09-13
PlS Planned sale
21,267 -62.0%
3.61
US$76,774 		21,267 -62.0% 3.61 US$76,774
2021-12-20 2021-12-17
US Veracyte Inc (VCYT)
PlS Planned sale
5,000 -36.4%
45.00
US$225,000 		5,000 -36.4% 45.00 US$225,000
2021-11-03 2021-11-01
US Veracyte Inc (VCYT)
PlS Planned sale
1,241 -100.0%
49.48
US$61,409 		1,241 -100.0% 49.48 US$61,409
2021-11-03 2021-11-01
US Veracyte Inc (VCYT)
PlS Planned sale
2,959 -70.5%
49,015.00
US$145,035,385 		2,959 -70.5% 49,015.00 US$145,035,385
2021-11-03 2021-11-01
US Veracyte Inc (VCYT)
PlS Planned sale
200 -4.5%
47.73
US$9,545 		200 -4.5% 47.73 US$9,545
2021-05-05 2021-05-03
US Veracyte Inc (VCYT)
PlS Planned sale
250 -2.8%
50.03
US$12,507 		250 -2.8% 50.03 US$12,507
2021-05-05 2021-05-03
US Veracyte Inc (VCYT)
PlS Planned sale
650 -6.7%
49.00
US$31,849 		650 -6.7% 49.00 US$31,849
2021-05-05 2021-05-03
US Veracyte Inc (VCYT)
PlS Planned sale
3,527 -26.7%
48.01
US$169,344 		3,527 -26.7% 48.01 US$169,344
2021-02-26 2021-02-25
US Veracyte Inc (VCYT)
PlS Planned sale
200 -100.0%
61.77
US$12,354 		200 -100.0% 61.77 US$12,354
2021-02-26 2021-02-25
US Veracyte Inc (VCYT)
PlS Planned sale
3,606 -94.7%
61.09
US$220,299 		3,606 -94.7% 61.09 US$220,299
2021-02-26 2021-02-25
US Veracyte Inc (VCYT)
PlS Planned sale
2,444 -39.1%
60.03
US$146,706 		2,444 -39.1% 60.03 US$146,706
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
100 -0.9%
296.78
US$29,678 		100 -0.9% 296.78 US$29,678
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
117 -1.1%
295.93
US$34,624 		117 -1.1% 295.93 US$34,624
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
232 -2.1%
294.73
US$68,378 		232 -2.1% 294.73 US$68,378
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
350 -3.0%
293.59
US$102,755 		350 -3.0% 293.59 US$102,755
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
134 -1.1%
292.27
US$39,164 		134 -1.1% 292.27 US$39,164
2019-01-04 2019-01-02
US Illumina Inc (ILMN)
PlS Planned sale
67 -0.6%
291.02
US$19,498 		67 -0.6% 291.02 US$19,498